1: Ye Y, Xu H, Quan L, Zhu L, Zeng J, Zhou T, Zou C, Cheng Q, Bu S, Tan W. The Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study. EBioMedicine. 2015 Feb 13;2(4):356-64. doi: 10.1016/j.ebiom.2015.02.006. PMID: 26137575; PMCID: PMC4485901.
2: Deng L, Wang S, Guo H, Liu X, Zou X, Zhang R, Lin Y, Tan W. (RS)-bambuterol and its enantiomers: Potential improvement of (R)-bambuterol in mice with colitis. Int Immunopharmacol. 2022 Feb;103:108501. doi: 10.1016/j.intimp.2021.108501. Epub 2021 Dec 30. PMID: 34974400.
3: Liu W, Cao Y, Lin Y, Tan KS, Zhao H, Guo H, Tan W. Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (R)-Bambuterol Treated Mice. Biology (Basel). 2021 May 5;10(5):404. doi: 10.3390/biology10050404. PMID: 34062954; PMCID: PMC8147965.
4: Zhou T, Zeng D, Zhao T, Yang Y, Liu S, Wu J, Xu L, Tan W. In vivo metabolism study of (R)-bambuterol in humans using ultra high performance liquid chromatography with tandem mass spectrometry. J Sep Sci. 2016 Aug;39(15):2896-906. doi: 10.1002/jssc.201600424. Epub 2016 Jun 27. PMID: 27273913.
5: Pistolozzi M, Du H, Wei H, Tan W. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates. Drug Metab Dispos. 2015 Mar;43(3):344-52. doi: 10.1124/dmd.114.060251. Epub 2014 Dec 11. PMID: 25504505.
6: Zhou T, Zhao T, Cheng Q, Liu S, Xu L, Tan W. A sensitive LC-MS/MS method for simultaneous determination of R-bambuterol and its active metabolite R-terbutaline in human plasma and urine with application to a clinical pharmacokinetic study. Biomed Chromatogr. 2014 Jul;28(7):994-1002. doi: 10.1002/bmc.3107. Epub 2013 Dec 20. PMID: 24357101.
7: Srinivas NR. Enantioselective Pharmacokinetics of Bambuterol in Preclinical Species: Does S-bambuterol Influence the Clearance of the R-antipode? Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):197-8. doi: 10.1007/s13318-015-0317-y. PMID: 26801943.
8: Guan S, Hu CY, He MY, Yang YY, Tang YX, Chen JD, Huang LJ, Tan W. Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs. Eur J Drug Metab Pharmacokinet. 2015 Dec;40(4):453-60. doi: 10.1007/s13318-014-0228-3. Epub 2014 Oct 4. PMID: 25281237.
9: Wu J, Liu F, Wang S, Wang H, Liu Q, Song X, Li J, Xu L, Tan W. Resolution of Rac-Bambuterol via Diastereoisomeric Salt Formation with o-Chloromandelic Acid and Differences in the Enantiomers' Pharmacodynamical Effects in Guinea Pigs and Beagles. Chirality. 2016 Apr;28(4):306-12. doi: 10.1002/chir.22573. Epub 2016 Jan 25. PMID: 26969816.
10: Bosak A, Gazić I, Vinković V, Kovarik Z. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers. Chem Biol Interact. 2008 Sep 25;175(1-3):192-5. doi: 10.1016/j.cbi.2008.04.050. Epub 2008 May 21. PMID: 18582854.